Israel’s OurCrowd has launched the OurCrowd Medtech Fund. The $50m fund will focus exclusively on investing in disruptive medical technologies and therapeutics with the potential to transform global healthcare delivery and patient outcomes.
OurCrowd fund for medical innovation
This entry was posted in Economy & Business. Bookmark the permalink.